Rubius Therapeutics
Event Partner

Rubius Therapeutics is a biopharmaceutical company that is developing a new class of cellular medicines called Red Cell Therapeutics™ (RCTs). The Company has designed a proprietary platform to genetically engineer red blood cells into medicines to treat a range of diseases. RCTs can potentially be used to replace missing enzymes for patients living with certain metabolic disorders, kill tumors in cancer and regulate the immune system for the treatment of autoimmune diseases.